Table: OncoTherapy Science -2023/24 parent results

OncoTherapy Science

10/05/2024 09:00

May 10 (Reuters)- 
          OncoTherapy Science Inc 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2024    Mar 31, 2023   Mar 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           0 mln           9 mln                                
               (-92.5 pct)     (+27.8 pct)                             
  Operating   loss 889 mln      loss 1.09                              
  Recurring   loss 873 mln      loss 1.09                              
  Net           loss 1.01       loss 1.12                              
  EPS         loss 4.74 yen   loss 5.80 yen                            
  Ann Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T